Metagenomi, Inc.
MGX
$1.86
-$0.05-2.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 106.28% | -57.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 106.28% | -57.07% | |||
| Cost of Revenue | -10.48% | 8.54% | |||
| Gross Profit | 33.41% | -55.09% | |||
| SG&A Expenses | 2.76% | -3.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.66% | 5.66% | |||
| Operating Income | 24.56% | -34.90% | |||
| Income Before Tax | 20.36% | -1.36% | |||
| Income Tax Expenses | -55.10% | 108.11% | |||
| Earnings from Continuing Operations | 20.49% | -7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.49% | -7.01% | |||
| EBIT | 24.56% | -34.90% | |||
| EBITDA | 25.74% | -38.10% | |||
| EPS Basic | 20.79% | -7.84% | |||
| Normalized Basic EPS | 25.81% | -43.82% | |||
| EPS Diluted | 20.79% | -7.84% | |||
| Normalized Diluted EPS | 25.81% | -43.82% | |||
| Average Basic Shares Outstanding | 0.37% | -0.77% | |||
| Average Diluted Shares Outstanding | 0.37% | -0.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||